The amount of glucose (sugar) consumed by internal organs rises during intense aerobic exercise, according to the researchers, which decreases the amount of energy available to the tumour. The study discovered how probability of cancer metastatic spread can be reduced by aerobic exercise.
Cancer cells require proteins that bind copper ions in order to develop and spread throughout the human body. Recent studies on the interactions between proteins and how they bind to metals in cancer-related proteins have revealed possible new therapeutic targets.
A recent study has found that membrane voltage being higher than in healthy cells it also fluctuates over time - with breast cancer cells behaving much like neurons.
Study revealed why metal copper are required by human cells to perform essential biological functions. The conclusion drawn from studies demonstrating higher copper levels in tumor cells and blood serum from cancer patients is that cancer cells require more copper than healthy cells.
The international team of researchers led by Elena Goun, an associate professor of chemistry at MU, discovered high levels of NR could not only increase someone's risk of developing triple-negative breast cancer, but also could cause cancer to metastasize or spread to the brain.
A group, led by researchers from the University of Edinburgh, discovered that TLR2 helps control some of the body's defense mechanisms when cancerous mutations occur in cells.
Singapore, November 11 (ANI/PRNewswire): Oncoshot and internationally recognised contract research organisation (CRO) Novotech have begun a partnership to enhance clinical trial management success. This collaborative partnership will grant exchange and insights into real-time population data
Some medications for these illnesses dissolve in water, making it impossible to carry them through the intestines, which process food and drink. As a result, these medications can't be taken by mouth. But UCR researchers have developed a chemical "tag" that can be attached to these medicatio
An experimental therapeutic cancer vaccine induced two distinct and desirable immune system responses that led to significant tumour regression in mice, report investigators.